Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 300

1.

Efficacy of α-blockers on hemodynamic control during pheochromocytoma resection - a randomized controlled trial.

Buitenwerf E, Osinga TE, Timmers HJLM, Lenders JWM, Feelders RA, Eekhoff EMW, Haak HR, Corssmit EPM, Bisschop PHLT, Valk GD, GrooteVeldman R, Dullaart RPF, Links TP, Voogd MF, Wietasch GJKG, Kerstens MN; PRESCRIPT-investigators.

J Clin Endocrinol Metab. 2019 Nov 12. pii: dgz188. doi: 10.1210/clinem/dgz188. [Epub ahead of print]

PMID:
31714582
2.

Pacing in vasovagal syncope: A physiological paradox?

de Jong JSY, Jardine DL, Lenders JWM, Wieling W.

Heart Rhythm. 2019 Sep 24. pii: S1547-5271(19)30855-0. doi: 10.1016/j.hrthm.2019.09.022. [Epub ahead of print]

PMID:
31561028
3.

Integrative multi-omics analysis identifies a prognostic miRNA signature and a targetable miR-21-3p/TSC2/mTOR axis in metastatic pheochromocytoma/paraganglioma.

Calsina B, Castro-Vega LJ, Torres-Pérez R, Inglada-Pérez L, Currás-Freixes M, Roldán-Romero JM, Mancikova V, Letón R, Remacha L, Santos M, Burnichon N, Lussey-Lepoutre C, Rapizzi E, Graña O, Álvarez-Escolá C, de Cubas AA, Lanillos J, Cordero-Barreal A, Martínez-Montes ÁM, Bellucci A, Amar L, Fernandes-Rosa FL, Calatayud M, Aller J, Lamas C, Sastre-Marcos J, Canu L, Korpershoek E, Timmers HJ, Lenders JW, Beuschlein F, Fassnacht-Capeller M, Eisenhofer G, Mannelli M, Al-Shahrour F, Favier J, Rodríguez-Antona C, Cascón A, Montero-Conde C, Gimenez-Roqueplo AP, Robledo M.

Theranostics. 2019 Jul 9;9(17):4946-4958. doi: 10.7150/thno.35458. eCollection 2019.

4.

Intricacies of the Molecular Machinery of Catecholamine Biosynthesis and Secretion by Chromaffin Cells of the Normal Adrenal Medulla and in Pheochromocytoma and Paraganglioma.

Berends AMA, Eisenhofer G, Fishbein L, Horst-Schrivers ANAVD, Kema IP, Links TP, Lenders JWM, Kerstens MN.

Cancers (Basel). 2019 Aug 6;11(8). pii: E1121. doi: 10.3390/cancers11081121. Review.

5.

Assessing outcomes after adrenalectomy for unilateral primary aldosteronism.

Williams TA, Lenders JWM, Reincke M.

Surgery. 2019 Aug 2. pii: S0039-6060(19)30416-7. doi: 10.1016/j.surg.2019.06.027. [Epub ahead of print] No abstract available.

PMID:
31383467
6.

Pheochromocytoma and Pregnancy.

Lenders JWM, Langton K, Langenhuijsen JF, Eisenhofer G.

Endocrinol Metab Clin North Am. 2019 Sep;48(3):605-617. doi: 10.1016/j.ecl.2019.05.006. Epub 2019 Jun 13. Review.

PMID:
31345526
7.

Impact of 123 I-MIBG scintigraphy on clinical decision making in pheochromocytoma and paraganglioma.

Rao D, van Berkel A, Piscaer I, Young WF, Gruber L, Deutschbein T, Fassnacht M, Beuschlein F, Spyroglou A, Prejbisz A, Hanus K, Eisenhofer G, Manelli M, Canu L, Lenders JWM, Bancos I, Timmers HJLM.

J Clin Endocrinol Metab. 2019 Mar 1. pii: jc.2018-02355. doi: 10.1210/jc.2018-02355. [Epub ahead of print]

PMID:
30822354
8.

The Primary Aldosteronism Surgical Outcome Score for the Prediction of Clinical Outcomes After Adrenalectomy for Unilateral Primary Aldosteronism.

Burrello J, Burrello A, Stowasser M, Nishikawa T, Quinkler M, Prejbisz A, Lenders JWM, Satoh F, Mulatero P, Reincke M, Williams TA.

Ann Surg. 2019 Jan 18. doi: 10.1097/SLA.0000000000003200. [Epub ahead of print]

PMID:
30672800
9.

Classification of microadenomas in patients with primary aldosteronism by steroid profiling.

Yang Y, Burrello J, Burrello A, Eisenhofer G, Peitzsch M, Tetti M, Knösel T, Beuschlein F, Lenders JWM, Mulatero P, Reincke M, Williams TA.

J Steroid Biochem Mol Biol. 2019 May;189:274-282. doi: 10.1016/j.jsbmb.2019.01.008. Epub 2019 Jan 14.

10.

Reference intervals for LC-MS/MS measurements of plasma free, urinary free and urinary acid-hydrolyzed deconjugated normetanephrine, metanephrine and methoxytyramine.

Eisenhofer G, Peitzsch M, Kaden D, Langton K, Mangelis A, Pamporaki C, Masjkur J, Geroula A, Kurlbaum M, Deutschbein T, Beuschlein F, Prejbisz A, Bornstein SR, Lenders JWM.

Clin Chim Acta. 2019 Mar;490:46-54. doi: 10.1016/j.cca.2018.12.019. Epub 2018 Dec 17.

11.

A steady state system for in vitro evaluation of steroidogenic pathway dynamics: Application for CYP11B1, CYP11B2 and CYP17 inhibitors.

Mangelis A, Jühlen R, Dieterich P, Peitzsch M, Lenders JWM, Hahner S, Schirbel A, Eisenhofer G.

J Steroid Biochem Mol Biol. 2019 Apr;188:38-47. doi: 10.1016/j.jsbmb.2018.12.003. Epub 2018 Dec 6.

PMID:
30529282
12.

Stress-inducible-stem cells: a new view on endocrine, metabolic and mental disease?

Bornstein SR, Steenblock C, Chrousos GP, Schally AV, Beuschlein F, Kline G, Krone NP, Licinio J, Wong ML, Ullmann E, Ruiz-Babot G, Boehm BO, Behrens A, Brennand A, Santambrogio A, Berger I, Werdermann M, Sancho R, Linkermann A, Lenders JW, Eisenhofer G, Andoniadou CL.

Mol Psychiatry. 2019 Jan;24(1):2-9. doi: 10.1038/s41380-018-0244-9. Epub 2018 Sep 21. No abstract available.

13.

Biochemical Diagnosis of Pheochromocytoma, a Rediscovered Catecholamine-Metabolizing Tumor.

Eisenhofer G, Lenders JWM.

Clin Chem. 2018 Dec;64(12):1780-1781. doi: 10.1373/clinchem.2018.290791. Epub 2018 Sep 10. Review. No abstract available.

PMID:
30201801
14.

Optimized Reference Intervals for Plasma Free Metanephrines in Patients With CKD.

Pamporaki C, Prejbisz A, Małecki R, Pistrosch F, Peitzsch M, Bishoff S, Mueller P, Meyer I, Reimann D, Hanus K, Januszewicz A, Bornstein SR, Parmentier S, Kunath C, Lenders JWM, Eisenhofer G, Passauer J.

Am J Kidney Dis. 2018 Dec;72(6):907-909. doi: 10.1053/j.ajkd.2018.06.018. Epub 2018 Aug 23. No abstract available.

PMID:
30146420
15.

Biochemical Diagnosis of Chromaffin Cell Tumors in Patients at High and Low Risk of Disease: Plasma versus Urinary Free or Deconjugated O-Methylated Catecholamine Metabolites.

Eisenhofer G, Prejbisz A, Peitzsch M, Pamporaki C, Masjkur J, Rogowski-Lehmann N, Langton K, Tsourdi E, Pęczkowska M, Fliedner S, Deutschbein T, Megerle F, Timmers HJLM, Sinnott R, Beuschlein F, Fassnacht M, Januszewicz A, Lenders JWM.

Clin Chem. 2018 Nov;64(11):1646-1656. doi: 10.1373/clinchem.2018.291369. Epub 2018 Aug 10.

16.

Immunohistopathology and Steroid Profiles Associated With Biochemical Outcomes After Adrenalectomy for Unilateral Primary Aldosteronism.

Meyer LS, Wang X, Sušnik E, Burrello J, Burrello A, Castellano I, Eisenhofer G, Fallo F, Kline GA, Knösel T, Kocjan T, Lenders JWM, Mulatero P, Naruse M, Nishikawa T, Peitzsch M, Rump LC, Beuschlein F, Hahner S, Gomez-Sanchez CE, Reincke M, Williams TA.

Hypertension. 2018 Sep;72(3):650-657. doi: 10.1161/HYPERTENSIONAHA.118.11465.

17.

Is the plasma aldosterone-to-renin ratio associated with blood pressure response to treatment in general practice?

Käyser SC, Schalk BWM, de Grauw WJC, Schermer TR, Akkermans RP, Lenders JWM, Deinum J, Biermans MCJ.

Fam Pract. 2019 Mar 20;36(2):154-161. doi: 10.1093/fampra/cmy039.

PMID:
29788258
18.

A pedunculated aldosterone-producing adenoma drained by an extra vein causing puzzling results of adrenal vein sampling.

Velema MS, Dekkers T, Hermus ARMM, Timmers HJLM, Langenhuijsen J, Arntz M, Kusters B, Eisenhofer G, Lenders JWM, Deinum J.

Clin Endocrinol (Oxf). 2018 May 9. doi: 10.1111/cen.13736. [Epub ahead of print] No abstract available.

PMID:
29741297
19.

Prevalence of primary aldosteronism in primary care: a cross-sectional study.

Käyser SC, Deinum J, de Grauw WJ, Schalk BW, Bor HJ, Lenders JW, Schermer TR, Biermans MC.

Br J Gen Pract. 2018 Feb;68(667):e114-e122. doi: 10.3399/bjgp18X694589. Epub 2018 Jan 15.

20.

Metabologenomics of Phaeochromocytoma and Paraganglioma: An Integrated Approach for Personalised Biochemical and Genetic Testing.

Eisenhofer G, Klink B, Richter S, Lenders JW, Robledo M.

Clin Biochem Rev. 2017 Apr;38(2):69-100. Review.

21.

The pathophysiology of the vasovagal response.

Jardine DL, Wieling W, Brignole M, Lenders JWM, Sutton R, Stewart J.

Heart Rhythm. 2018 Jun;15(6):921-929. doi: 10.1016/j.hrthm.2017.12.013. Epub 2017 Dec 12. Review.

22.

Adrenal Vein Sampling Is the Preferred Method to Select Patients With Primary Aldosteronism for Adrenalectomy: Con Side of the Argument.

Deinum J, Prejbisz A, Lenders JWM, van der Wilt GJ.

Hypertension. 2018 Jan;71(1):10-14. doi: 10.1161/HYPERTENSIONAHA.117.09294. No abstract available.

PMID:
29229748
23.

Primary Aldosteronism and Obstructive Sleep Apnea: Is This A Bidirectional Relationship?

Prejbisz A, Kołodziejczyk-Kruk S, Lenders JWM, Januszewicz A.

Horm Metab Res. 2017 Dec;49(12):969-976. doi: 10.1055/s-0043-122887. Epub 2017 Dec 4. Review.

PMID:
29202496
24.

Health-Related Quality of Life and Mental Health in Primary Aldosteronism: A Systematic Review.

Velema MS, de Nooijer AH, Burgers VWG, Hermus ARMM, Timmers HJLM, Lenders JWM, Husson O, Deinum J.

Horm Metab Res. 2017 Dec;49(12):943-950. doi: 10.1055/s-0043-121706. Epub 2017 Dec 4. Review.

PMID:
29202493
25.

Subtyping of Patients with Primary Aldosteronism: An Update.

Lenders JWM, Eisenhofer G, Reincke M.

Horm Metab Res. 2017 Dec;49(12):922-928. doi: 10.1055/s-0043-122602. Epub 2017 Dec 4. Review.

PMID:
29202492
26.

Patient characteristics do not predict the individual response to antihypertensive medication: a cross-over trial.

van der Wel MC, Biermans M, Akkermans R, Lenders JWM, van Weel C, Deinum J.

Fam Pract. 2018 Jan 16;35(1):67-73. doi: 10.1093/fampra/cmx075.

PMID:
28968870
27.

DIAGNOSIS OF ENDOCRINE DISEASE: 18-Oxocortisol and 18-hydroxycortisol: is there clinical utility of these steroids?

Lenders JWM, Williams TA, Reincke M, Gomez-Sanchez CE.

Eur J Endocrinol. 2018 Jan;178(1):R1-R9. doi: 10.1530/EJE-17-0563. Epub 2017 Sep 13. Review.

28.

Update on Modern Management of Pheochromocytoma and Paraganglioma.

Lenders JWM, Eisenhofer G.

Endocrinol Metab (Seoul). 2017 Jun;32(2):152-161. doi: 10.3803/EnM.2017.32.2.152. Review.

29.

Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort.

Williams TA, Lenders JWM, Mulatero P, Burrello J, Rottenkolber M, Adolf C, Satoh F, Amar L, Quinkler M, Deinum J, Beuschlein F, Kitamoto KK, Pham U, Morimoto R, Umakoshi H, Prejbisz A, Kocjan T, Naruse M, Stowasser M, Nishikawa T, Young WF Jr, Gomez-Sanchez CE, Funder JW, Reincke M; Primary Aldosteronism Surgery Outcome (PASO) investigators.

Lancet Diabetes Endocrinol. 2017 Sep;5(9):689-699. doi: 10.1016/S2213-8587(17)30135-3. Epub 2017 May 30.

30.

Reference intervals for plasma concentrations of adrenal steroids measured by LC-MS/MS: Impact of gender, age, oral contraceptives, body mass index and blood pressure status.

Eisenhofer G, Peitzsch M, Kaden D, Langton K, Pamporaki C, Masjkur J, Tsatsaronis G, Mangelis A, Williams TA, Reincke M, Lenders JWM, Bornstein SR.

Clin Chim Acta. 2017 Jul;470:115-124. doi: 10.1016/j.cca.2017.05.002. Epub 2017 May 4.

31.

Plasma methoxytyramine: clinical utility with metanephrines for diagnosis of pheochromocytoma and paraganglioma.

Rao D, Peitzsch M, Prejbisz A, Hanus K, Fassnacht M, Beuschlein F, Brugger C, Fliedner S, Langton K, Pamporaki C, Gudziol V, Stell A, Januszewicz A, Timmers HJLM, Lenders JWM, Eisenhofer G.

Eur J Endocrinol. 2017 Aug;177(2):103-113. doi: 10.1530/EJE-17-0077. Epub 2017 May 5.

32.

Adrenal Vein Catecholamine Levels and Ratios: Reference Intervals Derived from Patients with Primary Aldosteronism.

Sze CWC, O'Toole SM, Tirador RK, Akker SA, Matson M, Perry L, Druce MR, Dekkers T, Deinum J, Lenders JWM, Eisenhofer G, Drake WM.

Horm Metab Res. 2017 Jun;49(6):418-423. doi: 10.1055/s-0042-124419. Epub 2017 Apr 26.

PMID:
28445897
33.

Accuracy of recommended sampling and assay methods for the determination of plasma-free and urinary fractionated metanephrines in the diagnosis of pheochromocytoma and paraganglioma: a systematic review.

Därr R, Kuhn M, Bode C, Bornstein SR, Pacak K, Lenders JWM, Eisenhofer G.

Endocrine. 2017 Jun;56(3):495-503. doi: 10.1007/s12020-017-1300-y. Epub 2017 Apr 12. Review.

34.

Hydrochlorothiazide treatment increases the abundance of the NaCl cotransporter in urinary extracellular vesicles of essential hypertensive patients.

Pathare G, Tutakhel OAZ, van der Wel MC, Shelton LM, Deinum J, Lenders JWM, Hoenderop JGJ, Bindels RJM.

Am J Physiol Renal Physiol. 2017 Jun 1;312(6):F1063-F1072. doi: 10.1152/ajprenal.00644.2016. Epub 2017 Mar 8.

35.

Do we need to evaluate diastolic blood pressure in patients with suspected orthostatic hypotension?

Fedorowski A, Hamrefors V, Sutton R, van Dijk JG, Freeman R, Lenders JW, Wieling W.

Clin Auton Res. 2017 Jun;27(3):167-173. doi: 10.1007/s10286-017-0409-7. Epub 2017 Feb 27.

36.

Adrenal vein sampling versus CT scanning in primary aldosteronism - Authors' reply.

van der Wilt GJ, Dekkers T, Lenders JW, Deinum J.

Lancet Diabetes Endocrinol. 2016 Nov;4(11):886-887. doi: 10.1016/S2213-8587(16)30236-4. No abstract available.

PMID:
27793317
37.

Postural orthostatic tachycardia is not a useful diagnostic marker for chronic fatigue syndrome.

Roerink ME, Lenders JW, Schmits IC, Pistorius AM, Smit JW, Knoop H, van der Meer JW.

J Intern Med. 2017 Feb;281(2):179-188. doi: 10.1111/joim.12564. Epub 2016 Oct 2.

38.

Effects of Treating Primary Aldosteronism on Renal Function.

Kramers BJ, Kramers C, Lenders JW, Deinum J.

J Clin Hypertens (Greenwich). 2017 Mar;19(3):290-295. doi: 10.1111/jch.12914. Epub 2016 Sep 23.

39.

Adrenal vein sampling versus CT scan to determine treatment in primary aldosteronism: an outcome-based randomised diagnostic trial.

Dekkers T, Prejbisz A, Kool LJS, Groenewoud HJMM, Velema M, Spiering W, Kołodziejczyk-Kruk S, Arntz M, Kądziela J, Langenhuijsen JF, Kerstens MN, van den Meiracker AH, van den Born BJ, Sweep FCGJ, Hermus ARMM, Januszewicz A, Ligthart-Naber AF, Makai P, van der Wilt GJ, Lenders JWM, Deinum J; SPARTACUS Investigators.

Lancet Diabetes Endocrinol. 2016 Sep;4(9):739-746. doi: 10.1016/S2213-8587(16)30100-0. Epub 2016 Jun 17.

PMID:
27325147
40.

Study Heterogeneity and Estimation of Prevalence of Primary Aldosteronism: A Systematic Review and Meta-Regression Analysis.

Käyser SC, Dekkers T, Groenewoud HJ, van der Wilt GJ, Carel Bakx J, van der Wel MC, Hermus AR, Lenders JW, Deinum J.

J Clin Endocrinol Metab. 2016 Jul;101(7):2826-35. doi: 10.1210/jc.2016-1472. Epub 2016 May 12. Review.

PMID:
27172433
41.

MANAGEMENT OF ENDOCRINE DISEASE: Recurrence or new tumors after complete resection of pheochromocytomas and paragangliomas: a systematic review and meta-analysis.

Amar L, Lussey-Lepoutre C, Lenders JW, Djadi-Prat J, Plouin PF, Steichen O.

Eur J Endocrinol. 2016 Oct;175(4):R135-45. doi: 10.1530/EJE-16-0189. Epub 2016 Apr 14. Review.

PMID:
27080352
42.

European Society of Endocrinology Clinical Practice Guideline for long-term follow-up of patients operated on for a phaeochromocytoma or a paraganglioma.

Plouin PF, Amar L, Dekkers OM, Fassnacht M, Gimenez-Roqueplo AP, Lenders JW, Lussey-Lepoutre C, Steichen O; Guideline Working Group.

Eur J Endocrinol. 2016 May;174(5):G1-G10. doi: 10.1530/EJE-16-0033. Review.

PMID:
27048283
43.

Mass Spectrometry-Based Adrenal and Peripheral Venous Steroid Profiling for Subtyping Primary Aldosteronism.

Eisenhofer G, Dekkers T, Peitzsch M, Dietz AS, Bidlingmaier M, Treitl M, Williams TA, Bornstein SR, Haase M, Rump LC, Willenberg HS, Beuschlein F, Deinum J, Lenders JW, Reincke M.

Clin Chem. 2016 Mar;62(3):514-24. doi: 10.1373/clinchem.2015.251199. Epub 2016 Jan 19.

44.

Steroid Hormone Production in Patients with Aldosterone Producing Adenomas.

Moors M, Williams TA, Deinum J, Eisenhofer G, Reincke M, Lenders JW.

Horm Metab Res. 2015 Dec;47(13):967-72. doi: 10.1055/s-0035-1565225. Epub 2015 Dec 14. Review.

PMID:
26667800
45.

Cardiovascular Risk in Primary Hyperaldosteronism.

Prejbisz A, Warchoł-Celińska E, Lenders JW, Januszewicz A.

Horm Metab Res. 2015 Dec;47(13):973-80. doi: 10.1055/s-0035-1565124. Epub 2015 Nov 17. Review.

PMID:
26575306
46.

Genotype-Dependent Brown Adipose Tissue Activation in Patients With Pheochromocytoma and Paraganglioma.

Puar T, van Berkel A, Gotthardt M, Havekes B, Hermus AR, Lenders JW, van Marken Lichtenbelt WD, Xu Y, Brans B, Timmers HJ.

J Clin Endocrinol Metab. 2016 Jan;101(1):224-32. doi: 10.1210/jc.2015-3205. Epub 2015 Nov 17.

PMID:
26574955
47.

Genotype-Specific Steroid Profiles Associated With Aldosterone-Producing Adenomas.

Williams TA, Peitzsch M, Dietz AS, Dekkers T, Bidlingmaier M, Riester A, Treitl M, Rhayem Y, Beuschlein F, Lenders JW, Deinum J, Eisenhofer G, Reincke M.

Hypertension. 2016 Jan;67(1):139-45. doi: 10.1161/HYPERTENSIONAHA.115.06186. Epub 2015 Nov 16.

PMID:
26573708
48.

KCNJ5 Mutations: Sex, Salt and Selection.

Williams TA, Lenders JW, Burrello J, Beuschlein F, Reincke M.

Horm Metab Res. 2015 Dec;47(13):953-8. doi: 10.1055/s-0035-1565090. Epub 2015 Nov 13. Review.

PMID:
26566104
49.

Alternative splice variant of the thiazide-sensitive NaCl cotransporter: a novel player in renal salt handling.

Tutakhel OA, Jeleń S, Valdez-Flores M, Dimke H, Piersma SR, Jimenez CR, Deinum J, Lenders JW, Hoenderop JG, Bindels RJ.

Am J Physiol Renal Physiol. 2016 Feb 1;310(3):F204-16. doi: 10.1152/ajprenal.00429.2015. Epub 2015 Nov 11.

50.

Computational analysis of liquid chromatography-tandem mass spectrometric steroid profiling in NCI H295R cells following angiotensin II, forskolin and abiraterone treatment.

Mangelis A, Dieterich P, Peitzsch M, Richter S, Jühlen R, Hübner A, Willenberg HS, Deussen A, Lenders JW, Eisenhofer G.

J Steroid Biochem Mol Biol. 2016 Jan;155(Pt A):67-75. doi: 10.1016/j.jsbmb.2015.09.038. Epub 2015 Oct 3.

PMID:
26435452

Supplemental Content

Loading ...
Support Center